GBA Group Pharma has established the analysis of cannabis flowers according to the current German Pharmacopeia (DAB) – monograph. Since March 2017 #cannabis is also available on prescription in Germany under certain conditions. More and more patients are switching to alternative drugs such as medical cannabis if all current alternatives have so far failed to provide relief. Currently, cannabis sold in German pharmacies, is grown almost exclusively abroad. GBA Group Pharma can now perform release analysis. In this way we contribute to greater availability of different varieties and a more reliable market supply for patients.

Contact us:

GBA PHARMA GmbH

Tel. +49 731 97439-0

Email: info@gba-pharma.com